GlassScriptPhysician profile
Mahmoud Mima
NPI 1629592639
$6,863.51
in general payments reported to CMS, 2019-2025
11 companies · $739 in 2025
The $739 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,472 · 2020: $549 · 2021: $717 · 2022: $1,592 · 2023: $462 · 2024: $333 · 2025: $739.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,534.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,534.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $4,778.71 | 2019-2025 | Titan, Virtue |
| Boston Scientific Corporation | $1,158.20 | 2019-2025 | Lithovue, Ams 800 Artificial Urinary Sphincter, Lumenis Pulse 120h |
| Olympus America INC. | $425.10 | 2022-2025 | Itind System |
| Antares Pharma, INC. | $200.00 | 2022-2023 | Xyosted, Tlando |
| Procept Biorobotics Corporation | $149.32 | 2025 | |
| Astellas Pharma US INC | $43.16 | 2022 | |
| Janssen Pharmaceuticals, INC | $27.57 | 2021 | |
| Medtronic, INC. | $25.45 | 2023 | Interstim |
| Urogen Pharma, INC. | $22.57 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $17.62 | 2019 | |
| Convatec INC. | $15.81 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mahmoud Mima listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.